Reaction
Intermittent Claudication reporting signals
As of the last recalculation, Intermittent Claudication appears in 1,574 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is NILOTINIB (PRR 83.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nilotinib | 167 | 83.7 | 84.1 |
| Basiliximab | 15 | 17.0 | 17.0 |
| Quinine | 10 | 15.5 | 15.5 |
| Clopidogrel | 200 | 15.1 | 15.2 |
| Tolterodine Tartrate | 10 | 14.8 | 14.8 |
| Bosutinib | 10 | 14.8 | 14.8 |
| Isosorbide Dinitrate | 21 | 14.4 | 14.4 |
| Rasagiline Mesylate | 12 | 14.4 | 14.4 |
| Amiodarone Hydrochloride | 12 | 14.3 | 14.3 |
| Clopidogrel Bisulfate | 100 | 13.7 | 13.8 |
| Enalapril Maleate | 25 | 13.5 | 13.5 |
| Nitroglycerin | 53 | 13.5 | 13.5 |
| Ezetimibe And Simvastatin | 15 | 13.2 | 13.2 |
| Digoxin | 65 | 12.5 | 12.5 |
| Quinapril Hydrochloride | 7 | 11.8 | 11.8 |
| Losartan Potassium And Hydrochlorothiazide | 10 | 11.5 | 11.5 |
| Dasatinib | 31 | 11.2 | 11.2 |
| Levodopa | 10 | 11.0 | 11.0 |
| Ticagrelor | 26 | 10.9 | 11.0 |
| Nebivolol | 13 | 10.9 | 10.9 |
| Tenofovir Disoproxil Fumarate Tablets | 7 | 10.8 | 10.8 |
| Terazosin Hydrochloride | 7 | 10.4 | 10.5 |
| Amlodipine Besylate And Benazepril Hydrochloride | 7 | 10.1 | 10.1 |
| Darbepoetin Alfa | 39 | 9.8 | 9.8 |
| Piperacillin And Tazobactam | 9 | 9.4 | 9.4 |
| Norepinephrine | 7 | 8.7 | 8.7 |
| Eplerenone | 8 | 8.3 | 8.3 |
| Ranolazine | 6 | 7.6 | 7.6 |
| Norepinephrine Bitartrate | 8 | 7.4 | 7.4 |
| Imatinib | 9 | 6.8 | 6.8 |
| Tenofovir Disoproxil Fumarate | 10 | 4.0 | 4.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 3.9 | 3.9 |
| Hydrocodone Bitartrate | 11 | 3.4 | 3.4 |
| Evolocumab | 20 | 1.6 | 1.6 |